Green Strategy to Develop Novel Drug-Containing Poly (ε-Caprolactone)-Chitosan-Silica Xerogel Hybrid Fibers for Biomedical Applications

Figure 3

(a) FT-IR spectra, (b) TG curves, and (c) DSC profiles of different samples.

(a)

(b)

(c)